Use of amino acid-chelated zinc in treating lung cancer

TW202641491APending Publication Date: 2026-10-16FAAC BIO INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114113406
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-04-09
Publication Date
2026-10-16

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Use of amino acid-chelated zinc in the manufacture of a pharmaceutical composition is provided, wherein the pharmaceutical composition is used for treating lung cancer, and particularly treating lung cancer with EGFR (Epidermal Growth Factor Receptor) gene mutation or resistance toepidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI).
Need to check novelty before this filing date? Find Prior Art